Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Testosterone undecanoate + d-alpha tocopherol is a **combination drug** composed of testosterone undecanoate, an androgen and anabolic steroid used for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism, and d-alpha tocopherol, a natural form of vitamin E often used as an antioxidant. **Testosterone undecanoate** acts as a prodrug of testosterone, which binds to the androgen receptor to regulate development and maintenance of male secondary sex characteristics and other physiological functions. **D-alpha tocopherol** provides antioxidant activity, protecting cells from oxidative stress, and stabilizes oil-based injection formulations. This combination may be used in some intramuscular injectable formulations to enhance stability or tolerability, but it is not a major marketed product under a unique brand name.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on testosterone undecanoate + d-alpha tocopherol.